Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Apple on Wednesday is widely expected to introduce its iPhone 18 handsets, including its first folding-screen model. The post Apple Poised To Unveil Folding iPhone appeared first on Investor’s Business Daily.
Zscaler stock fell amid fiscal Q4 earnings that topped estimates while the outlook for a key metric in fiscal 2027 underwhelmed. The post Zscaler Dips On Fiscal 2027 Outlook For Key Sales Metric appeared first on Investor’s Business Daily.
Samsara stock popped amid Q2 earnings and revenue topped estimates while the company’s October-quarter revenue guidance came in above views. The post Samsara Earnings, Revenue, Outlook Top Consensus Estimates appeared first on Investor’s Business Daily.
Zscaler stock popped amid fiscal Q4 earnings that topped estimates while October quarter guidance came in above views. The post Zscaler Stock Wavers On Cybersecurity Firm’s Earnings Beat, Outlook appeared first on Investor’s Business Daily.
Ambarella narrowly beat estimates for its fiscal second quarter and matched views with its sales forecast for fiscal Q3. AMBA stock wavered in extended trading. The post Chipmaker Ambarella Posts Mixed Fiscal Q2 Earnings Report appeared first on Investor’s Business…
Summit Therapeutics stock rocketed Thursday after its experimental cancer drug outperformed Merck’s blockbuster, Keytruda. The post Summit Packs A Punch For Merck’s Keytruda — But Not Everyone Is Sold appeared first on Investor’s Business Daily.
Broadcom expects its artificial intelligence-related sales to double next year and again the following year. Broadcom stock fell Thursday. The post Broadcom Forecasts Steep Ramp In AI Revenue appeared first on Investor’s Business Daily.
HPE stock fell amid fiscal Q3 earnings and revenue that topped estimates with high expectations for AI infrastructure growth. The post Why HPE Stock Is Falling Amid Fiscal Q3 Earnings Beat appeared first on Investor’s Business Daily.
Snowflake stock jumped amid Q2 earnings and revenue that handily beat estimates while guidance came in well above expectations. The post Snowflake Earnings Beat. Why Snowflake’s AI Product Strategy Is Jelling. appeared first on Investor’s Business Daily.
Climb Bio reversed course Thursday despite potential “best-in-class” data for its experimental kidney disease treatment. The post Why Climb Bio, Up 1,300% Over 17 Months, Just Skidded appeared first on Investor’s Business Daily.
